The DOI matches its Crossref record; 148 of the 151 references it cites were found in a registry or an index.
Endosomal escape pathways for delivery of biologicals
Open accessAbstract
Despite continuous improvements in delivery systems, the development of methods for efficient and specific delivery of targeted therapeutic agents still remains an issue in biological treatments such as protein and gene therapy. The endocytic pathway is the major uptake mechanism of cells and any biological agents, such as DNA, siRNA and proteins. These agents become entrapped in endosomes and are degraded by specific enzymes in the lysosome. Thus, a limiting step in achieving an effective biological based therapy is to facilitate the endosomal escape and ensure cytosolic delivery of the therapeutics. Bacteria and viruses are pathogens which use different mechanisms to penetrate the membranes of their target cells and escape the endosomal pathway. Different mechanisms such as pore formation in the endosomal membrane, pH-buffering effect of protonable groups and fusion into the lipid bilayer of endosomes have been proposed to facilitate the endosomal escape. Several viral and bacterial proteins have been identified that are involved in this process. In addition, chemical agents and photochemical methods to rupture the endosomal membrane have been described. New synthetic biomimetic peptides and polymers with high efficacy in facilitating the endosomal escape, low pathogenicity and toxicity have been developed. Each strategy has different characteristics and challenges for designing the best agents and techniques to facilitate the endosomal escape are ongoing. In this review, several mechanisms and agents which are involved in endosomal escape are introduced.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,605
ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
Mellman, I., Fuchs, R., & Helenius, A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003311 · Cited by 2,045
Lewin, M., Carlesso, N., Tung, C., Tang, X. S., Cory, D. G., Scadden, D. T., & Weissleder, R. (2000) · Nature Biotechnology · doi:10.1038/74464 · Cited by 1,716
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M., Glorioso, J., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,444
THE STRUCTURE AND FUNCTION OF THE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFLUENZA VIRUS
Wiley, D. C., & Skehel, J. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002053 · Cited by 1,413
Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent
Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., & Prochiantz, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18188 · Cited by 1,073
The actions of melittin on membranes
Dempsey, C. E. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(90)90006-x · Cited by 852
Stepwise dismantling of adenovirus 2 during entry into cells
Greber, U. F., Willetts, M., Webster, P. C., & Helenius, A. (1993) · Cell · doi:10.1016/0092-8674(93)90382-z · Cited by 811
Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
Al-Dosari, M. S., & Gao, X. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9143-y · Cited by 706
Cited by
Sorted by citations
Items 701–800 of 1,000
AL Qtaish, N., Gallego, I., Paredes, A. J., Villate-Beitia, I., Soto-Sánchez, C., Martínez-Navarrete, G., Sainz-Ramos, M., Lopez-Mendez, T. B., Fernández, E., Puras, G., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c02182 · Cited by 29
Zhang, J., Wang, Z., Liao, Y., Tong, J., Gao, R., Zeng, Z., Bai, Y., Wei, Y., & Guo, X. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.11.041 · Cited by 29
Biosynthesis of Lysosomally Escaped Apoptotic Bodies Inhibits Inflammasome Synthesis in Macrophages
Mao, J., Xia, W., Wu, Y., Li, M., Zhao, Y., Zhai, P., Zhang, Y., Zan, T., Cui, W., & Sun, X. (2024) · Research · doi:10.34133/research.0581 · Cited by 29
Santhamoorthy, M., Bharathiraja, S., Manivasagan, P., Lee, K. D., & Oh, J. (2017) · New Journal of Chemistry · doi:10.1039/c7nj02432k · Cited by 29
Functionalized Spiky Particles for Intracellular Biomolecular Delivery
Chen, H., Hang, T., Yang, C., Liu, D., Chen, S., Xiao, S., Liu, C., Lin, D. H., Zhang, T., Jin, Q., et al. (2019) · ACS Central Science · doi:10.1021/acscentsci.8b00749 · Cited by 28
Two-Dimensional Nanosheet-Based Photonic Nanomedicine for Combined Gene and Photothermal Therapy
Kim, N. Y., Blake, S., De, D., Ouyang, J., Shi, J., & Kong, N. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01573 · Cited by 29
Li, C., Cao, X., Zhao, J., & Wang, F. (2020) · The Journal of Membrane Biology · doi:10.1007/s00232-020-00109-2 · Cited by 31
Huang, H., Yuan, S., Ma, Z., Ji, P., Ma, X., Wu, Z., & Qi, X. (2020) · Biomaterials Science · doi:10.1039/c9bm01822k · Cited by 29
Stimuli-responsive nanoparticles based on poly acrylic derivatives for tumor therapy
Li, K., Zang, X., Cheng, M., & Chen, X. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120506 · Cited by 30
BSA-magnetite nanotorpedo for safe and efficient delivery of chemotherapy drugs
Zhao, X., Xu, S., Jiang, Y. Q., Wang, C., Rehman, S. U., Ji, S., Wang, J., Tao, T., Xu, H., Chen, R., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.140440 · Cited by 28
Cardiac gene therapy: Recent advances and future directions
Mason, D., Chen, Y., Krishnan, H. V., & Sant, S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.001 · Cited by 29
Nanomedicine: The Promise and Challenges in Cancer Chemotherapy
Naguib, Y. W., & Cui, Z. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-8739-0_11 · Cited by 28
Reducible Amino Acid Based Cationic Lipids as Highly Efficient and Serum‐Tolerant Gene Vectors
Zheng, L., Yi, W., Su, R., Liu, Q., & Zhao, Z. (2015) · ChemPlusChem · doi:10.1002/cplu.201500307 · Cited by 30
Santhamoorthy, M., Kim, H.-B., Bae, J.-H., Kim, S.-H., & Ha, C. (2016) · RSC Advances · doi:10.1039/c5ra28143a · Cited by 29
Delivery of Nucleic Acids for Cancer Gene therapy: Overcoming extra- and intra-cellular Barriers
McErlean, E. M., McCrudden, C. M., & McCarthy, H. O. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0049 · Cited by 29
Charge‐Reversal Polymers for Biodelivery
Zhang, B., Wang, K., Si, J., Sui, M., & Shen, Y. (2014) · Wiley eBooks · doi:10.1002/9783527672752.ch9 · Cited by 29
Nanoparticles Used for the Delivery of RNAi-Based Therapeutics
Ren, T., Ma, L., Fu, P., & Zhang, C. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111502 · Cited by 31
Weiß, V., Argyo, C., Torrano, A. A., Strobel, C., Mackowiak, S. A., Schmidt, A., Datz, S., Gatzenmeier, T., Hilger, I., Bräuchle, C., et al. (2016) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2016.03.017 · Cited by 28
Nanomedicines Based on Recombinant Fusion Proteins for Targeting Therapeutic siRNA Oligonucleotides
Winkler, J. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.56 · Cited by 28
Impact of the Structure of Biocompatible Aliphatic Polycarbonates on siRNA Transfection Ability
Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Hendrick, E., Peulen, O., Évrard, B., Dúbois, P., Mespouille, L., Mottet, D., et al. (2015) · Biomacromolecules · doi:10.1021/bm501676p · Cited by 29
A Cell-Penetrating Peptide with a Guanidinylethyl Amine Structure Directed to Gene Delivery
Oba, M., Kato, T., Furukawa, K., & Tanaka, M. (2016) · Scientific Reports · doi:10.1038/srep19913 · Cited by 28
Ravera, M., Gabano, E., Zanellato, I., Gallina, A., Perin, E., Arrais, A., Cantamessa, S., & Osella, D. (2017) · Dalton Transactions · doi:10.1039/c6dt03749f · Cited by 28
Tamemoto, N., Akishiba, M., Sakamoto, K., Kawano, K., Noguchi, H., & Futaki, S. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00312 · Cited by 28
Aliyandi, A., Zuhorn, I. S., & Salvati, A. L. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.599454 · Cited by 30
Huang, L., Asghar, S., Zhu, T., Ye, P., Hu, Z., Chen, Z., & Xiao, Y. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1950685 · Cited by 28
Peptide-Assisted Nucleic Acid Delivery Systems on the Rise
Tarvirdipour, S., Skowicki, M., Schoenenberger, C., & Palivan, C. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169092 · Cited by 30
pH-Responsive Nano Carriers for Doxorubicin Delivery
Bagherifam, S., Skjeldal, F. M., Griffiths, G. W., Mælandsmo, G. M., Engebråten, O., Nyström, B., Hasırcı, V., & Hasırcı, N. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1530-0 · Cited by 28
Cornelissen, B. T. (2014) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3152 · Cited by 28
Mbong, G. N. N., Lu, Y., Chan, C., Cai, Z., Liu, P., Boyle, A. J., Winnik, M. A., & Reilly, R. M. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5007618 · Cited by 28
Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for siRNA Delivery
Xu, W., Ran, P., Zhao, D., Chu, D., Wu, Y. F., Wang, R., Chen, B., Ding, Y., Sadatmousavi, P., Yuan, Y., et al. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500429u · Cited by 28
A Triple-Fluorophore-Labeled Nucleic Acid pH Nanosensor to Investigate Non-viral Gene Delivery
Wilson, D. R., Routkevitch, D., Rui, Y., Mosenia, A., Wahlin, K. J., Quiñones‐Hinojosa, A., Zack, D. J., & Green, J. J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.04.008 · Cited by 28
Kopp, M., Rotan, O., Papadopoulos, C., Schulze, N., Meyer, H. H., & Epple, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178260 · Cited by 30
Exploring the role of peptides in polymer-based gene delivery
Sun, Y., Yang, Z. L., Wang, C., Yang, T., Cai, C., Zhao, X., Yang, L., & Ding, P. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.07.043 · Cited by 28
Smart Synthetic Polymer Nanocarriers for Controlled and Site-Specific Drug Delivery
Balaure, P. C., & Grumezescu, A. M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150414115852 · Cited by 30
Hybrid Smart Mesoporous Silica Nanoparticles for Theranostics
Baleizão, C., & Farinha, J. P. S. (2015) · Nanomedicine · doi:10.2217/nnm.15.102 · Cited by 28
Yeoh, Y. Q., Amin, A., Cuic, B., Tomas, D., Turner, B. J., & Shabanpoor, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116737 · Cited by 29
Bresinskya, M., & Göpferich, A. M. (2025) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2025.114634 · Cited by 30
Zhang, Y., Lundberg, P., Diether, M., Porsch, C., Janson, C., Lynd, N. A., Ducani, C., Malkoch, M., Malmström, E., Hawker, C. J., et al. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb02051k · Cited by 27
Blenke, E. O., Śleszyńska, M., Evers, M. J. W., Storm, G., Martin, N. I., & Mastrobattista, E. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00677 · Cited by 27
Self-citationXu, B., Zhu, Y., Wang, C.-H., Qiu, C., Sun, J., Yan, Y., Chen, X., Wang, J., & Zhang, Q. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b04301 · Cited by 27
pH-Sensitive Polymers as Dynamic Mediators of Barriers to Nucleic Acid Delivery
Peeler, D. J., Sellers, D. L., & Pun, S. H. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00695 · Cited by 28
Biodegradable Block Copolymers and Their Applications for Drug Delivery
Soni, V., Pandey, V., Asati, S., Gour, V., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817909-3.00011-x · Cited by 27
Key considerations in designing CRISPR/Cas9-carrying nanoparticles for therapeutic genome editing
Xu, Y., Liu, R., & Dai, Z. (2020) · Nanoscale · doi:10.1039/d0nr05452f · Cited by 27
Chong, G., Su, R., Gu, J., Yang, Y., Zhang, T., Zang, J., Zhao, Y., Zheng, X. W., Liu, Y., Ruan, S., et al. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.134993 · Cited by 27
More than Toxins—Current Prospects in Designing the Next Generation of Antibody Drug Conjugates
Schwach, J., Abdellatif, M., & Stengl, A. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2708240 · Cited by 27
Transfection reagent artefact likely accounts for some reports of extracellular vesicle function
McConnell, R. E., Youniss, M. R., Gnanasambandam, B., Shah, P. M., Zhang, W., & Finn, J. D. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12253 · Cited by 33
Rehmani, S., McLaughlin, C. M., Eltaher, H. M., Moffett, R. C., Flatt, P. R., & Dixon, J. E. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.006 · Cited by 31
Kweon, D., Shin, Heo, Yang, Cho, Yoon, Y., Shin, Seo, & Kim (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29817 · Cited by 27
Dördelmann, G., Kozlova, D., & Epple, M. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01052c · Cited by 27
Spatio-temporal control of cellular uptake achieved by photoswitchable cell-penetrating peptides
Prestel, A., & Möller, H. M. (2015) · Chemical Communications · doi:10.1039/c5cc06848g · Cited by 27
Immunoprotein-Mediated siRNA Delivery
Bäumer, N., Berdel, W. E., & Bäumer, S. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01039 · Cited by 28
Antitumor Features of Vegetal Protein-Based Nanotherapeutics
Voci, S., Gagliardi, A., Fresta, M., & Cosco, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010065 · Cited by 27
Lee, W., Kim, Y.-K., Zhang, Q., Park, T., Kang, S., Kim, D. W., Cho, C., & Choi, Y. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.10.005 · Cited by 26
Song, N., Zhou, L., Li, J., Pan, Z., He, X., Tan, H. S., Wan, X., Li, J., Ran, R., & Fu, Q. (2016) · Nanoscale · doi:10.1039/c6nr00859c · Cited by 26
He, M., Lillian, R., Liu, J., & Chu, C. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35924 · Cited by 26
Lunn, A. M., Unnikrishnan, M., & Perrier, S. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00554 · Cited by 26
Peptide therapeutics in the management of metastatic cancers
Bose, D., Roy, L., & Chatterjee, S. (2022) · RSC Advances · doi:10.1039/d2ra02062a · Cited by 27
Proteoid biodynamers for safe mRNA transfection via pH-responsive nanorods enabling endosomal escape
Lee, S., Nasr, S. S., Rasheed, S., Liu, Y., Hartwig, O., Kaya, C., Boese, A. S., Koch, M., Herrmann, J. E., Müller, R., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.018 · Cited by 26
Grazú, V., Moros, M., & Sánchez‐Espinel, C. (2012) · Frontiers of nanoscience · doi:10.1016/b978-0-12-415769-9.00014-5 · Cited by 27
Yiu, H. H. P., Bouffier, L., Boldrin, P., Long, J., Claridge, J. B., & Rosseinsky, M. J. (2013) · Langmuir · doi:10.1021/la400848r · Cited by 26
Wang, L., Ariyarathna, Y., Ming, X., Yang, B., James, L. I., Kreda, S. M., Porter, M. A., Janzen, W. P., & Juliano, R. L. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00242 · Cited by 26
Song, X., You, J., Shao, H., & Yan, C. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.05.024 · Cited by 26
Endosomal escape of protein nanoparticles engineered through humanized histidine-rich peptides
López‐Laguna, H., Cubarsí, R., Unzueta, U., Mangues, R., Vázquez, E., & Villaverde, A. (2019) · Science China Materials · doi:10.1007/s40843-019-1231-y · Cited by 26
Smart chemistry for traceless release of anticancer therapeutics
Prange, C. J., Hu, X., & Tang, L. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122353 · Cited by 26
Gu, X., Tai, Y., Liu, Z., Zhang, X., Liu, K., Zhou, L., Yin, W., Deng, Y., Kong, D., Midgley, A. C., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304675 · Cited by 27
Zhang, L., Lou, W., & Wang, J. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01463-4 · Cited by 30
Clinical Applications of Antisense Oligonucleotides in Cancer: A Focus on Glioblastoma
Khuu, A., Verreault, M., Colin, P., Tran, H., & Idbaïh, A. (2024) · Cells · doi:10.3390/cells13221869 · Cited by 25
Liu, Z., Wu, J., Wang, N., Lin, Y., Song, R., Zhang, M., & Li, B. (2025) · Nature Communications · doi:10.1038/s41467-025-59501-y · Cited by 25
Bingr, Z., Shi, H., & Liu, Y. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01760b · Cited by 25
Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge
Colombo, S., Zeng, X., Ragelle, H., & Foged, C. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.927439 · Cited by 27
Gu, J., Hao, J., Fang, X., & Sha, X. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.023 · Cited by 25
Upconversion nanoparticles as intracellular pH messengers
Tsai, E. S., Joud, F., Wiesholler, L. M., Hirsch, T., & Hall, E. A. H. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02768-5 · Cited by 25
Metabolite-Based Modification of Poly( l -lysine) for Improved Gene Delivery
Urello, M. A., Xiang, L., Colombo, R., Ma, A., Joseph, A., Boyd, J., Peterson, N. C., Gao, C., Wu, H., & Christie, R. J. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00614 · Cited by 25
Han, X., Xu, X. D., Wu, Z., Wu, Z., & Qi, X. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.009 · Cited by 25
Sun, B., Zhao, X., Gu, W., Cao, P., Movahedi, F., Wu, Y., Xu, Z. P., & Gu, W. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01408k · Cited by 25
Fuchs, H., Bachran, C., & Flavell, D. J. (2013) · Antibodies · doi:10.3390/antib2020209 · Cited by 25
An efficient nonviral gene-delivery vector based on hyperbranched cationic glycogen derivatives
Yang, L., Liang, X., Ren, X., Liu, Z., Liu, Y., Wang, J., Wang, J., Zhang, L., Deng, D. Y. B., & Quan, D. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s51919 · Cited by 25
Deng, Z. J., Morton, S. W., Bonner, D. K., Gu, L., Ow, H., & Hammond, P. T. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.013 · Cited by 25
Beaudoin, S., Rondeau, A., Martel, O., Bonin, M., van Lier, J. E., & Leyton, J. V. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00075 · Cited by 25
Kangarlou, S., Ramezanpour, S., Balalaie, S., Mohammadi, S. R., & Haririan, I. (2016) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1261301 · Cited by 25
Current Status of Messenger RNA Delivery Systems
Stanton, M. G. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0726 · Cited by 26
Lu, D., An, Y., Feng, S., Li, X., Fan, A., Wang, Z., & Zhao, Y. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1092-2 · Cited by 25
Zhang, T., Song, X., Kang, D., Zhang, L., Zhang, C., Jin, S., Wang, C., Tian, J., Xing, J., & Liang, X. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00548e · Cited by 24
Liao, X., & Ju, H. (2014) · Chemical Communications · doi:10.1039/c4cc09097g · Cited by 24
Badwaik, V. D., Liu, L., Gunasekera, D. S., Kulkarni, A., & Thompson, D. H. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00078 · Cited by 24
Ma, L., Bygd, H. C., & Bratlie, K. M. (2016) · Integrative Biology · doi:10.1039/c6ib00133e · Cited by 23
Zhang, Y., Qu, Q., Cao, X. S., & Zhao, Y. (2017) · Chemical Communications · doi:10.1039/c7cc07897h · Cited by 24
Ibrahim, A., Twizeyimana, E., Lu, N., Ke, W., Mukerabigwi, J. F., Mohammed, F., Japir, A. A.-W. M. M., & Ge, Z. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00769 · Cited by 24
Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19
Nalawansha, D. A., & Samarasinghe, K. T. G. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00071 · Cited by 24
Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy
Gao, M., Deng, H., & Zhang, W. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200922113846 · Cited by 24
McErlean, E. M., McCrudden, C. M., McBride, J. W., Cole, G., Kett, V. L., Robson, T., Dunne, N., & McCarthy, H. O. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120223 · Cited by 24
Ahmed, K. S., Liu, S., Mao, J. Y., Zhang, J., & Qiu, L. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s317454 · Cited by 24
Hausig, F., Sobotta, F. H., Richter, F., Harz, D. O., Traeger, A., & Brendel, J. C. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00829 · Cited by 24
Rational preparation and application of a mRNA delivery system with cytidinyl/cationic lipid
Li, L., Long, J., Sang, Y., Wang, X., Zhou, X., Pan, Y., Cao, Y., Huang, H., Yang, Z., Yang, J., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.10.023 · Cited by 24
Antibody-drug conjugate and free geldanamycin combination therapy enhances anti-cancer efficacy
McCombs, J. R., Chang, H., Shah, D. K., & Owen, S. C. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121272 · Cited by 24
Emergence of mRNA vaccines in the management of cancer
Razif, M. I. M., Nizar, N., Abidin, N. H. Z., Ali, S. N. M., Zarimi, W. N. N. W., Khotib, J., Darnis, D. S., Jailani, M. T. M., & Taher, M. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2232450 · Cited by 23
Wang, X., Wang, M., Cai, M., Shao, R., Xia, G., & Zhao, W. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.009 · Cited by 24
Targeting Wnt-β-Catenin Signaling Pathway for Hepatocellular Carcinoma Nanomedicine
Bakrania, A. K., To, J. C., Zheng, G., & Bhat, M. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.07.012 · Cited by 26
Andrian, T., Muela, Y., Delgado, L., Albertazzi, L., & Pujals, S. (2023) · Nanoscale · doi:10.1039/d3nr02838k · Cited by 24
Nair, B. G., Fukuda, T., Mizuki, T., Hanajiri, T., & Maekawa, T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.080 · Cited by 24
Metadata
- Authors
- Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J.
- Affiliations
- Utrecht University (NL)
- University of Groningen (NL)
- Corresponding author
- Haisma, Hidde J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 151
- Issue
- 3
- Pages
- 220-228
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2008028087
- Cited by
- 1,561
- References
- 151
- Citations by year
- 2026: 82 · 2025: 82 · 2024: 90 · 2023: 94 · 2022: 122 · 2021: 100 · 2020: 123 · 2019: 120 · 2018: 137 · 2017: 111 · 2016: 127 · 2015: 116 · 2014: 98 · 2013: 90 · 2012: 51
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- endosomal escape, endocytosis, lysosomal degradation, protein delivery, gene delivery, siRNA delivery, viral fusion, pH buffering, biomimetic peptides, polymers, biologic therapy
- MeSH terms
- Animals, Cytosol, DNA, Drug Carriers, Endocytosis, Humans, Intracellular Membranes, Membrane Fusion, Models, Biological, Proteins, Endosomes, RNA, Small Interfering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review